Alk Protac Medchemexpress

CDK9-PROTAC
564169 5.0mg
EUR 630

Human IgG antibody Laboratories manufactures the alk protac medchemexpress reagents distributed by Genprice. The Alk Protac Medchemexpress reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact MedChemExpress Inc.. Other Alk products are available in stock. Specificity: Alk Category: Protac Group: Medchemexpress

Human True insulin ELISA kit
1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True insulin ELISA kit
96T
EUR 700
Description: ELISA

Human True Insulin ELISA Kit
10x96-Strip-Wells
EUR 6725

Human True Insulin ELISA Kit
48-Strip-Wells
EUR 550

Human True Insulin ELISA Kit
5x96-Strip-Wells
EUR 3420

Human True Insulin ELISA Kit
96-Strip-Wells
EUR 765

Human True Insulin GENLISA ELISA
1 x 96 wells
EUR 286

Medchemexpress information

PROTAC BET degrader-2
HY-114228 25mg
EUR 2607.6

PROTAC BET degrader-3
HY-114229 10mg
EUR 1230

PROTAC BET Degrader-1
HY-103633 25mg
EUR 2607.6

PROTAC RAR Degrader-1
HY-111844 1mg
EUR 817.2

PROTAC ERα Degrader-2
HY-111846 50mg
EUR 3985.2

PROTAC ERα Degrader-1
HY-112098 10mM/1mL
EUR 4304.4

PROTAC IRAK4 ligand-3
HY-145484 Get quote Ask for price
Description: PROTAC IRAK4 ligand-3 is a ligand of PROTAC IRAK4 degrader-7 (HY-145483). PROTAC IRAK4 ligand-3 can be used for the research of cancer[1].

PROTAC EGFR degrader 4
HY-146349 Get quote Ask for price
Description: PROTAC EGFR degrader 4 is a potent PROTAC targeting mutant EGFR.PROTAC EGFR degrader 4 induces EGFRdel19 and EGFRL858R/T790M degradation with DC50s of 0.51 and 126 nM, respectively. PROTAC EGFR degrader 4 significantly inhibits growth of HCC827 and H1975 cell lines with IC50s of 0.83 and 203.1 nM, respectively. Induced EGFR degradation is related to autophagy[1].

PROTAC EGFR degrader 5
HY-146422 Get quote Ask for price
Description: PROTAC EGFR degrader 5 (Compound 10), a PROTAC EGFR degrader, potently degrades EGFRDel19 in HCC827 cells with the DC50 of 34.8 nM. PROTAC EGFR degrader 5 significantly induces the apoptosis of HCC827 cells and arrest the cells in G1 phase[1].

PROTAC EGFR degrader 6
HY-146423 Get quote Ask for price
Description: PROTAC EGFR degrader 6, a PROTAC EGFR degrader, potently degrades EGFRDel19 in HCC827 cells with the DC50 of 45.2 nM. PROTAC EGFR degrader 6 significantly induces the apoptosis of HCC827 cells and arrest the cells in G1 phase[1].

PROTAC EED degrader-1
HY-130614 10 mg
EUR 1244.61
Description: PROTAC EED degrader-1 is a von Hippel-Lindau-based PROTAC targeting EED with a pKD of 9.02. PROTAC EED degrader-1 is a polycomb repressive complex 2 (PRC2) inhibitor (pIC50=8.17) targeting the EED subunit[1].

PROTAC EED degrader-2
HY-130615 10 mg
EUR 1028.15
Description: PROTAC EED degrader-2 is a von Hippel-Lindau-based PROTAC targeting EED with a pKD of 9.27. PROTAC EED degrader-2 is a polycomb repressive complex 2 (PRC2) inhibitor (pIC50=8.11) targeting the EED subunit[1].

PROTAC BTK Degrader-3
HY-153536 Get quote Ask for price
Description: PROTAC BTK Degrader-3 is a potent BTK degrader with a DC50 value of 10.9 nM of BTK degradation in Mino cells. PROTAC BTK Degrader-3 has the potential for B-cell malignancies, including chronic lymphoid malignancies research[1].

PROTAC TTK degrader-1
HY-143904 1 mg
EUR 6580.19
Description: PROTAC TTK degrader-1 is a potent TTK (threonine tyrosine kinase) PROTAC degrader, with DC50 values of 1.7 and 5.8 nM in COLO-205 and HCT-116 cell, respectively. PROTAC TTK degrader-1 exhibits target degradation and anticancer efficacy in a xenograft mouse model of COLO-205 human colorectal cancer cells[1].

PROTAC TTK degrader-2
HY-143905 Get quote Ask for price
Description: PROTAC TTK degrader-2 is a potent TTK (threonine tyrosine kinase) PROTAC degrader, with DC50 values of 3.1 and 12.4 nM in COLO-205 and HCT-116 cell, respectively. PROTAC TTK degrader-2 exhibits target degradation and anticancer efficacy in a xenograft mouse model of COLO-205 human colorectal cancer cells[1].

PROTAC EGFR degrader 2
HY-144304 1 mg
EUR 1448.07
Description: PROTAC EGFR degrader 2 is a potent PROTAC EGFR degrader. PROTAC EGFR degrader 2 exhibits excellent antiproliferative activity with IC50 of 4.0 nM and good EGFR degradation activity with DC50 of 36.51 nM. PROTAC EGFR degrader 2 can be used for the synthesis of nitroreductase (NTR)-responsive PROTAC[1].

PROTAC EGFR degrader 3
HY-144605 1 mg
EUR 2326.88
Description: PROTAC EGFR degrader 3 is a potent PROTAC EGFR degrader. PROTAC EGFR degrader 3 shows excellent cellular activity against the H1975 and HCC827 cells with high selectively. PROTAC EGFR degrader 3 shows that the lysosome is involved in the degradation process of EGFR mutant degradation[1].